3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
≥98%
- Product Code: 65000
Alias:
T5224;T 5224
CAS:
530141-72-1
| Molecular Weight: | 517.53 g./mol | Molecular Formula: | C₂₉H₂₇NO₈ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28053483 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily researched for its potential therapeutic applications, particularly in the treatment of inflammatory diseases. Its mechanism of action involves the inhibition of specific enzymes or pathways that contribute to inflammation, making it a candidate for conditions such as arthritis, asthma, and other autoimmune disorders. Additionally, its structural features suggest it may have applications in modulating immune responses, potentially aiding in the development of novel immunosuppressive therapies. Ongoing studies are exploring its efficacy and safety profile for clinical use.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Powder |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿2,980.00 |
+
-
|
| 0.005 | 10-20 days | ฿5,530.00 |
+
-
|
| 0.025 | 10-20 days | ฿16,820.00 |
+
-
|
3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
This compound is primarily researched for its potential therapeutic applications, particularly in the treatment of inflammatory diseases. Its mechanism of action involves the inhibition of specific enzymes or pathways that contribute to inflammation, making it a candidate for conditions such as arthritis, asthma, and other autoimmune disorders. Additionally, its structural features suggest it may have applications in modulating immune responses, potentially aiding in the development of novel immunosuppressive therapies. Ongoing studies are exploring its efficacy and safety profile for clinical use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :